AI EEG Explained for EEG Technologists

Most of what gets written about AI EEG is aimed at physicians or at hospital executives. Technologists tend to hear about it second hand, usually as a rumor that software is going to change how the lab works.

The reality is narrower and more useful than the rumor. AI EEG tools operate on a specific part of the workflow, and understanding which part makes it easier to judge what they will and will not change about the job.

Where the Technologist Sits in the Workflow

Before anything is automated, the technologist has already done the work that determines whether automation is useful. Patient setup and instruction and event annotation during acquisition all happen before a single algorithm runs.

That sequence matters. Detection tools work from the recording the technologist produced, which is why the setup and annotation work comes first.

The technologist’s clinical contribution is upstream of the AI, which is why the AI does not replace it.

What the Algorithms Actually Do

Two capabilities are worth understanding specifically.

Spike detection uses AI enabled algorithms to automatically identify spikes. These are markers used in diagnosing and managing epilepsy, and finding them manually across a long recording is time consuming work.

Seizure detection uses deep learning algorithms to identify seizure events automatically. That feature was validated through thousands of hours of nineteen channel EEG data, and the system notifies physicians of detected seizures within an hour.

Both features are FDA cleared for clinical use. Both produce candidate events rather than conclusions. Auto detected events are tabulated for review and assessment, and physicians can review, validate, or adjust detected events based on their clinical expertise.

That is the design in one sentence. The software finds candidates. The physician decides.

What Artifact Reduction Covers

Artifact reduction in NeuroMatch is FDA cleared for muscle and eye artifacts. It is useful across long studies where muscle activity and eye movement accumulate over days, but it reduces those artifacts rather than removing them entirely, and it does not address other artifact types.

The honest framing is that artifact reduction improves what a physician sees where muscle and eye artifact appears.

What Changes in the Technologist’s Day

The visible change is in the routine administrative work rather than in the clinical work.

An omnibus patient care platform minimizes the need for multiple systems, which reduces the number of applications a technologist moves between during a shift. Embedded workflow automation including electronic physician signature, automated annotation, and digital archiving decreases time wasted on tasks that have to happen but add nothing clinically.

Digital archiving is worth calling out. In many labs, getting a completed study into the right place involves manual steps that vary by which system recorded it. When studies are uploaded into one cloud platform, that step becomes consistent.

What Does Not Change

Patient care remains the technologist’s responsibility, and none of that is automatable in the way the marketing language sometimes implies.

Annotation during acquisition also remains valuable. A technologist who notes that a patient was eating, or that a family member was in the room, is recording context the algorithm has no access to. That context is often exactly what allows a physician to distinguish an artifact from a finding.

The clinical relationship with the patient is entirely unchanged. Long term monitoring patients spend days in a unit, and the technologist is often the person they see most.

Working With a Tabulated Event List

One practical shift is worth preparing for. When a study comes back with a list of detected events attached, that list becomes part of the handoff to the reading physician.

Technologists in units using these tools generally find it useful to understand what the detection is looking for, because it helps them put the event list in context when a physician asks about it.

It also helps in conversations with physicians. When a reader asks why a stretch of the recording produced what it did, the technologist who was present usually has the answer.

What to Ask When a Lab Adopts These Tools

• Which capabilities are cleared for clinical use here, and which are not?
• What is the technologist’s role in the workflow after the study is uploaded?
• Does the platform replace any system the lab currently uses, or add to it?
• How does the study get from the acquisition system into the platform?
• What training is provided, and who provides it?
• Can the technologist see what was detected, or only the physician?

Labs that work through these questions during rollout tend to have a smoother transition than ones that discover the answers during the first week of use.

The Bigger Context

The reason these tools exist is capacity. The demand for neurological diagnosis exceeds what the healthcare system can currently supply, and the shortage of neurologists has been described by the American Academy of Neurology as a grave threat. EEG volume has grown faster than the number of people available to read it.

Automated detection addresses part of that gap by reducing the time a physician spends searching. It does not address the acquisition side, which is where technologist capacity sits, and labs adopting these tools should not expect them to.

In Practice

LVIS NeuroMatch® is a cloud based EEG software platform with muscle and eye artifact reduction, FDA cleared spike and seizure detection, twenty four hour trending summaries, longitudinal patient reports, automated reporting, and role based access controls. Studies are uploaded to the cloud and reached through a web browser rather than from a designated reader station.

NeuroMatch® has received regulatory clearance in the United States and Korea. LVIS Corporation holds ISO 13485 certification for its medical device quality management system.

The Short Version

AI EEG tools work on the search problem inside a recording. They find candidate spikes and seizures, reduce muscle and eye artifact, summarize long studies, and automate parts of the reporting tail.

They do not prepare or manage a patient, or interpret a study. Those remain where they have always been, which is with the people in the lab and the physician doing the read.

To see how NeuroMatch® fits your lab’s workflow, request a demo.